OPRX - OptimizeRx says preliminary 2023 revenue expected to exceed previously announced guidance range of $68-$70M
2024-01-09 08:38:12 ET
More on OptimizeRx
- OptimizeRx Growth Prospects Look Intriguing
- OptimizeRx jumps after guidance raise
- OptimizeRx beats Q3 top and bottom line estimates; initiates FY24 and updates FY23 outlook
- Seeking Alpha’s Quant Rating on OptimizeRx
For further details see:
OptimizeRx says preliminary 2023 revenue expected to exceed previously announced guidance range of $68-$70M